Fetal obesity syndrome: Maternal nutrition as a cause of nonalcoholic steatohepatitis
M. Charlton
DOI: https://doi.org/10.1002/hep.23371
IF: 17.298
2009-12-01
Hepatology
Abstract:Having children has its blessings and its downsides. The blessings are usually obvious and typically greatly outweigh the downsides. The downsides, however, are not trivial, and they are sometimes unexpected. My son was recently suspended from his soccer team for a verbal exchange with an opposing coach, which revolved principally around the alacrity of what the coach was saying to the referee (we have a school system where it can be heroic to question Darwin, but the opinion of a soccer coach is strictly off limits). My son should have known better, but rather than apologize or express remorse, as he came off the field he blamed his altercation and suspension on me for passing on the genes of my famously mercurial father. It was tempting to point out that if he had the time to bemoan the parts of his genetic code that had made it impossible for him to suffer the petty indignities of school sports in silence, he should also consider being more grateful for those genes that were responsible for him having a total of 20 digits and two functioning eyes. As I struggled to suppress a reflexive apoplexy it occurred to me that, at some level, he had been right. Just as children are a mixed blessing, so are parents. If anything, my son had understated the biological impact of parents on their children. The rising global prevalence of obesity has been well documented. The World Health Organization estimates that, worldwide, 1.6 billion adults are overweight (defined as body mass index [BMI] 25 kg/m2) and 400 million are obese (BMI 30 kg/m2). According to the most recent National Health and Nutrition Education Survey (NHANES), two-thirds of adults in the United States are overweight or obese.1 There are more than 1 million Americans with a BMI 60 kg/m2 (NHANES III data estimates).1 The average adult gained 10 pounds in the 1990s. Although the overall prevalence of obesity has recently begun to plateau, the prevalences of the most severe classes of obesity are rising sharply, with a dramatic shift to the right in BMI distribution. Class III obesity (BMI 40 kg/m2) quadrupled and BMI 50 kg/m2 quintupled2 between 1986 and 2000. Mercifully, although the prevalence and severity of obesity are high, only a small proportion of obese individuals develop nonalcoholic steatohepatitis (NASH) with progressive fibrosis. A conservative estimate of the frequency of nonalcoholic fatty liver disease (NAFLD) as the underlying cause of liver disease among liver transplant recipients is 5%-10% (equivalent to 350-700 total patients, http:// www.ustransplant.org/)—a tiny fraction of patients with NAFLD. The basis for disparate histological findings seen in the livers of patients with obesity is one of the great scientific questions facing academic hepatologists. The physiology of steatosis is no mystery. Simple overnutrition can produce a net accumulation of hepatic fat (just order foie gras). Similarly, oxidative stress is an inevitable byproduct of metabolizing carbohydrates and lipids.3 The concept and some of the mechanisms of lipoapoptosis, a consequence of lipid-induced oxidative injury, are increasingly well established. Intrahepatic free fatty acids (FFAs) are potent inducers of the apoptosis receptors Fas and tumor necrosis factor–related apoptosis-inducing ligand (TRAIL).4 Overnutrition, even with simple carbohydrate excess, sensitizes hepatocytes to apoptosis through increased expression of Fas.5 Further contributing to oxidative stress and injury, intrahepatic FFA excess results in mitochondrial dysfunction associated with release of cathepsin B from lysozomes.6 Cathepsin B knockout mice are protected against overnutrition-associated oxidative hepatocellular injury, suggesting a possible mechanistic role for cathepsin B in steatohepatitis. In addition, reactive oxygen species mediate release of tumor necrosis factor alpha (TNF) by Kupffer cells and hepatocytes.7 TNFincreases mitochondrial permeability, impairs mitochondrial respiration, and causes depletion of mitochondrial cytochrome c and further release of cathepsin B. Both TNF–induced caspase activation and hepatocyte death (apoptosis) are increased in NAFLD.8 Finally, lipid peroxidation results in the production of malondialdehyde and 4-hydroxynonenal, which serve as chemoattractants for neutrophils (necroinflammation), stimulate hepatic stellate cells (fibrosis), and up-regulate Abbreviations: BMI, body mass index; ETC, electron transport chain; FFA, free fatty acid; HF, high fat; NAFLD, nonalcoholic fatty liver disease; NASH, nonalcoholic steatohepatitis; NHANES, National Health and Nutrition Education Survey; TGF1, transforming growth factor-beta 1; TNFtumor necrosis factor alpha; TRAIL, tumor necrosis factor–related apoptosis-inducing ligand. Address reprint requests to: Michael Charlton, M.D., Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street S.W., Rochester, MN 55905. E-mail: charlton.michael@mayo.edu; fax: 507-266-1856. Copyright © 2009 by the American Association for the Study of Liver Diseases. Published online in Wiley InterScience (www.interscience.wiley.com). DOI 10.1002/hep.23371 Potential conflict of interest: Nothing to report.